My company has to intellectual property office submitted edaravone in injection of a patent application, access to acceptance.

The adr as the products of our company has the important meaning of the strategy of one of the products, since 2000 the product research, obtained clinical entity 2009 received bureau issued manufacturing since the approval, in edaravone in the products, the company has been for this product into the scientific research into a huge sum of money, a number of technical stard broke through the existing international level, especially for edaravone in water-soluble solution of the problems have made remarkable breakthrough, is solved by edaravone in can only low concentration problems, the technology has to patent form submitted to the intellectual property office, the intellectual property rights protection.

At the same time I ?